BioLineRx Ltd.
AGI-134 COMBINED WITH A CHECKPOINT INHIBITOR FOR THE TREATMENT OF SOLID TUMORS

Last updated:

Abstract:

A method of treating a tumor in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of: i) Pembrolizumab; and ii) a lipid having a structural formula as illustrated in FIG. 1 (AGI-134).

Status:
Application
Type:

Utility

Filling date:

27 May 2019

Issue date:

29 Apr 2021